Cargando…
Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
Ceramide synthases (CerS) are central enzymes required for the de-novo synthesis of ceramides and other sphingolipids. They catalyze the addition of different acyl-chains to a sphingoid base, and thus account for much of the rich diversity in the sphingolipid family. Recent studies have demonstrated...
Autor principal: | Raichur, Suryaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403459/ https://www.ncbi.nlm.nih.gov/pubmed/32849276 http://dx.doi.org/10.3389/fendo.2020.00483 |
Ejemplares similares
-
Mechanistic interplay between ceramide and insulin resistance
por: Reali, Federico, et al.
Publicado: (2017) -
The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
por: Field, Bianca C., et al.
Publicado: (2020) -
Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
por: Hilvo, Mika, et al.
Publicado: (2020) -
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice
por: Ziegler, Nicole, et al.
Publicado: (2020) -
Ceramides in Adipose Tissue
por: Li, Ying, et al.
Publicado: (2020)